Background/aims The pattern scan laser photocoagulator (PASCAL) is a novel laser device that uses 10–30 ms pulse duration for retina photocoagulation. The aim of this study was to analyse the safety profile of this approach.
Methods This was a retrospective study. We reviewed the clinical records of all laser sessions performed with PASCAL from November 2007 to July 2008. Where there were any complications, we recorded the laser parameters, type, affected retina region, postoperative interval and treatment if required.
Results There were 1301 consecutive cases. Complications included 17 cases of retinal bleeding (1.3%), two cases of choroidal detachment (0.15%) and one case of exudative retinal detachment (0.07%). There was no statistical difference between the laser parameters used in patients with or without complications.
Conclusion The laser parameters for PASCAL are safe. The complications and adverse effects encountered in this series are similar to those reported in other studies.
- diabetic retinopathy, panretinal photocoagulation
- pattern scan laser
- treatment lasers
Statistics from Altmetric.com
Funding The study was completely sponsored by the hospital research program.
Competing interests GRM is employed by OptiMedica Corporation and has a proprietary interest in the PASCAL Photocoagulator. The remaining authors do not have financial or economic interest on the publication of this manuscript.
Patient consent Obtained.
Ethics approval The study was conducted according the tenets of the Declaration of Helsinki and was also approved by the ethics committee of our institution, which depends directly on the Ministry of Health.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.